-
Loading metrics
Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma
- Heather L. Gardner,
- Sarah B. Rippy,
- Misty D. Bear,
- Kim L. Cronin,
- Heather Heeb,
- Holly Burr,
- Claire M. Cannon,
- Kumar V. Penmetsa,
- Srikant Viswanadha,
- Swaroop Vakkalanka
x
- Published: April 24, 2018
- https://doi.org/10.1371/journal.pone.0195357